Delta-tocotrienol supplementation improves biochemical markers of hepatocellular injury and steatosis in patients with nonalcoholic fatty liver disease: A randomized, placebo-controlled trial.

CONCLUSION: δ-tocotrienol effectively improved biochemical markers of hepatocellular injury and steatosis in patients with NAFLD. δ-tocotrienol supplementation might be considered as a therapeutic option in the management of patients with NAFLD. TRIAL REGISTRATION: Sri Lankan Clinical Trials Registry (SLCTR/2015/023, 2015-10-03). PMID: 32951743 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/32951743?dopt=Abstract

Source: Complementary Therapies in Medicine - July 31, 2020 Category: Complementary Medicine Authors: Pervez MA, Khan DA, Slehria AUR, Ijaz A Tags: Complement Ther Med Source Type: research